Hang Seng Biotech IndexHSBIOValuation Analysis
Valuation Snapshot
Based on the blended 10-year P/E and P/B percentiles, this index currently sits in the “Fair Value Range” zone.
As of 2026-10-16, Hang Seng Biotech Index (HSBIO) trades at a P/E of 30.40x and a P/B of 3.16x.
Longitudinal percentile comparison: P/E sits at the 33.55th percentile over the trailing 10Y window (vs. 64.14th percentile over 3Y); P/B sits at the 59.79th percentile over the trailing 10Y window (vs. 78.35th percentile over 3Y).
Data refreshes weekly and is for reference only, not investment advice.
Want the full picture on whether Hang Seng Biotech Index (HSBIO) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E & P/B percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|
| P/E | 30.40 | ||||
| P/B | 3.16 |